Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma

Gynecologic Oncology

Volumn 75, Issue 3, 1999, Pages 453-459

  Zhai, Ya Li ^a   Nikaido, Toshio ^a   Orii, Ayaka ^a   Horiuchi, Akiko ^a   Toki, Toshihiko ^a   Fujii, Shingo ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Leiomyoma; Leiomyosarcoma; Loss of heterozygosity; Tumor suppressor genes

Indexed keywords

DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERUS SARCOMA;

EID: 0032762958     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5629     Document Type: Article

References (40)

1. Zaloudek, C, J, Norris, H, J, Mesenchymal tumours of the uterus, in, Kurman, R, J, (ed), Blausteins's Pathology of the Female Genital Tract, 4th ed, New York, Springer-Verlag, 1994, pp, 849, - 914.
2. Vogelstein B, Fearon E R, Kern S E, Hamilton S R, Preisinger A C, Nakamura Y, White R. Allelotype of colorectal carcinomas. Science. 244:1989;207-221.
3. Mao L, Lee D J, Tockman M S, Erozan Y S, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA. 91:1994;9871-9875.
4. Mao L, Schoenberg M P, Scicchitano M, Erozan Y S, Merlo A, Schwab D, Sidransky D. Molecular detection of primary bladder cancer by microsatellite analysis. Science. 271:1996;659-662.
5. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jacquemier J, Sobol H, Eisinger F, Birnbaum D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res. 57:1997;5469-5474.
6. DE Vos S, Wilczynski S P, Fleischhacker M, Koeffler P. p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol Oncol. 54:1994;205-208.
7. Jeffers M D, Farquharson M A, Richmond J A, McNiel M. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus. J Pathol. 177:1995;65-70.
8. Zhai Y-L, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I, Fujii S. The expression of steroid receptors, Ki-67, and p53 in leiomyosarcomas of the uterus. Int J Gynecol Pathol. 18:1999;20-28.
9. Dal Cin P, Boghosian L, Crickard K, Sandberg A A. t(10; 17) as the sole chromosome change in a uterine leiomyosarcoma. Cancer Genet Cytogenet. 32:1988;263-266.
10. Havel G, Dahlenfors R, Wedell B, Mark J. Similar chromosomal evolution in a uterine stromomyosarcoma and in one of two leiomyomas from the same patient. Apmis. 97:1989;143-146.
11. Nilbert M, Mandahl N, Heim S, Rydholm A, Helm G, Willén H, Baldetorp B, Mitelman F. Complex karyotypic changes including rearrangements of 12q13 and 14q24, in two leiomyosarcomas. Cancer Genet Cytogenet. 48:1990;217-223.
12. Nilbert M, Jin Y S, Heim S, Mandahl N, Flodérus U M, Willén H, Mitelman F. Chromosome rearrangements in two uterine sarcomas. Cancer Genet Cytogenet. 44:1990;27-35.
13. Fletcher J A, Morton C C, Pavelka K, Lage J M. Chromosome aberration in uterine smooth muscle tumours: Potential diagnostic relevance of cytogenetic instability. Cancer Res. 50:1990;4092-4097.
14. Nibert M, Heim S. Uterine leiomyoma cytogenetics. Genet Chrom Cancer. 2:1990;3-13.
15. Kiechle-Schwarz M, Sreekantaiah C, Berger C S, Pedron S, Medchill M T, Surti U, Sandberg A A. Nonrandom cytogenetic changes in leiomyomas of the female genitourinary tract: A report of 35 cases. Cancer Genet Cytogenet. 53:1991;125-136.
16. Cornelisse C J, Kuipers-Dijkshoorn N, van Vliet M, Hermans J, Devilee P. Fractional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss. Int J Cancer. 50:1992;544-548.
17. Yee C J, Roodi N, Verrier C S, Parl F F. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res. 54:1994;1641-1644.
18. Peiffer S L, Herzog T J, Tribune D J, Mutch D G, Gersell D J, Goodfellow P J. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 55:1995;1922-1926.
19. Gabra H, Watson J E, Taylor K J, Mackay J, Leonard R C, Steel C M, Porteous D J, Smyth J F. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res. 56:1996;950-954.
20. Wistuba I I, Montellano F D, Milchgrub S, Virmani A K, Behrens C, Chen H, Ahmadian M, Nowak J A, Muller C, Minna J D, Gazdar A F. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res. 57:1997;3154-3158.
21. Hendrickson M R, Kempson R L. Pure mesenchymal neoplasms of the uterine corpus. Fox H, Wells H. Obstetrical and Gynecological Pathology. 1995;542-573 Churchill Livingstone, Edinburgh.
22. Creasman W T. Announcement, FIGO stage: 1988 revisions. Gynecol Oncol. 35:1989;125-127.
23. Turbett G R, Barnett T C, Dillon E K, Sellner L N. Single-tube protocol for the extraction of DNA or RNA from paraffin-embedded tissues using a starch-based adhesive. BioTechniques. 20:1996;846-850.
24. Cawkwell L, Lewis F A, Quirke P. Frequency of allele loss of DCC, p53, RB1, WT1, NF1, NM23, and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer. 70:1994;813-818.
25. Hahn S A, Hoque A T, Moskaluk C A, da Costa L T, Schutte M, Rozenblum E, Seymour A B, Weinstein C L, Yeo C J, Hruban R H, Kern S E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56:1996;490-494.
26. Cawkwell L, Bell S M, Lewis F A, Dixon M F, Taylor G R, Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer. 67:1993;1262-1267.
27. Young J, Leggett B, Ward M, Thomas L, Buttenshaw R, Searle J, Chenevix-Trench G. Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene. 8:1993;671-675.
28. Bandera C A, Takahashi H, Behbakht K, Liu P C, Livolsi V A, Benjamin I, Morgan M A, King S A, Rubin S C, Boyd J. Deletion mapping of two potential chromosome 14 tumour suppressor gene loci in ovarian carcinoma. Cancer Res. 57:1997;513-515.
29. Chang W Y, Cairns P, Schoenberg M P, Polascik T J, Sidransky D. Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res. 55:1995;3246-3249.
30. Rosin M P, Cairns P, Epstein J I, Schoenberg M P, Sidransky D. Partial allelotype of carcinoma in situ of the human bladder. Cancer Res. 55:1995;5213-5216.
31. Phillips N J, Ziegler M R, Radford K L, Steinbrueck T, Xynos F P, Donis-Keller H. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res. 56:1996;606-611.
32. Zhai Y-L, Nikaido T, Toki T, Shiozawa T, Orii A, Fujii S. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus. Br J Cancer. 80:1999;1658-1664.
33. Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y. Loss of heterozygosity at the p53, RB, DCC and APC tumour suppressor gene loci in human bladder cancer. J Urol. 155:1996;1444-1447.
34. Reed A L, Califano J, Cairns P, Westra W H, Jones R M, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D. High frequency of P16 (Cdkn2/Mts-1/Ink4a) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56:1996;3630-3633.
35. Van Der Riet P, Nawroz H, Hruban R H, Corio R, Tokino K, Koch W, Sidransky D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 54:1994;1156-1158.
36. Park W-S, Vortmeyer A O, Pack S, Duray P H, Boni R, Guerami A A, Emmert-Buck M R, Liotta L A, Zhuang Z. Allelic deletion at chromosome 9p21(P16) and 17p13(P53) in microdissected sporadic dysplastic nevus. Hum Pathol. 29:1998;127-130.
37. Bosnar M H, Pavelic K, Hrascan R, Zeljko Z, Krhen I, Marekoyic Z, Krizanac S, Pavelic J. Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas. J Cancer Res Clin Oncol. 123:1997;485-488.
38. Seifert M, Theisinger B, Engel M, Seib T, Seitz G, Stolte M, Hilgert K, Welter C. Isolation and characterization of new microsatellites at the nm23-H1 and nm23-H2 gene loci and application for loss of heterozygosity (LOH) analysis. Hum Genet. 100:1997;515-519.
39. Kikuchi-Yanoshita R, Konishi M, Fukunari H, Tanaka K, Miyaki M. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 52:1992;3801-3803.
40. Risinger J I, Umar A, Boyer J C, Evans C A, Berchuck A, Kunkel T A, Barrett J C. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. Cancer Res. 55:1995;5664-5669.